Waypoint Bio secures USD 14.5Mln seed funding to turbocharge drug discovery
Waypoint Bio (aka “Waypoint”), a biotechnology company pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology, recently announced $14.5 million in seed funding led by Hummingbird Ventures with participation from other institutional investors, including Recode Ventures and pre-seed lead Fifty Years. The FDA recently approved the first ever cell therapy for solid tumors, […]
Seroba and Kurma Partners announce completion of total series B financing round of EUR 65.8Mln
Seroba, an European life sciences venture capital firm headquartered in Dublin, with offices in Paris and Milan, and Kurma Partners, a key European Venture Capital firm financing innovation in Healthcare and Biotechnology, from pre-seed to growth capital, based in Paris and Munich, announced yesterday the completion of the second closing part of Series B financing […]
Veristat Appoints Gabriela Rosu, M.D., as Senior Director of Global Medical Affairs Team
Veristat, the Science-First Full Service CRO and Consultancy announced that Gabriela Rosu, M.D., has joined as Senior Director of Global Medical Affairs. Dr Rosu is a seasoned professional with over twenty years of experience in scientific and clinical fields, having significantly contributed to the planning and execution of pivotal activities that have led to the approval […]
